IRON Financial LLC boosted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 9,366 shares of the company’s stock after acquiring an additional 299 shares during the quarter. IRON Financial LLC’s holdings in Colgate-Palmolive were worth $851,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also added to or reduced their stakes in CL. Union Bancaire Privee UBP SA purchased a new position in Colgate-Palmolive in the 4th quarter worth $32,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the third quarter valued at about $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive in the third quarter worth about $53,000. Prospera Private Wealth LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $64,000. Finally, True Wealth Design LLC boosted its holdings in Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analysts Set New Price Targets
CL has been the subject of several recent research reports. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Finally, Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $101.11.
Insiders Place Their Bets
In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.34% of the company’s stock.
Colgate-Palmolive Price Performance
CL stock opened at $91.19 on Tuesday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The firm has a 50 day moving average price of $91.81 and a 200-day moving average price of $97.45. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The firm has a market capitalization of $74.50 billion, a price-to-earnings ratio of 26.13, a PEG ratio of 3.59 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Sizing Up a New Opportunity for NVIDIA Investors
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- NYSE Stocks Give Investors a Variety of Quality Options
- The 3 Biggest M&A Stock Opportunities for 2025
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.